Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about President Trump’s new pick for surgeon general, Zepbound beating ...

Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

Kim Kardashian arrived at a Paris court to testify against the gang members accused of holding her at gunpoint and robbing ...

Billy and Tina, the last two Asian elephants at the Los Angeles Zoo, were set to be moved to a new location at the Tulsa Zoo, ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...